10.25384/SAGE.6396683.v1
Dorothea Buck
Dorothea
Buck
Till FM Andlauer
Till FM
Andlauer
Wilmar Igl
Wilmar
Igl
Eva-Maria Wicklein
Eva-Maria
Wicklein
Mark Mühlau
Mark
Mühlau
Frank Weber
Frank
Weber
Karl Köchert
Karl
Köchert
Christoph Pohl
Christoph
Pohl
Barry Arnason
Barry
Arnason
Giancarlo Comi
Giancarlo
Comi
Stuart Cook
Stuart
Cook
Massimo Filippi
Massimo
Filippi
Hans-Peter Hartung
Hans-Peter
Hartung
Douglas Jeffery
Douglas
Jeffery
Ludwig Kappos
Ludwig
Kappos
Frederik Barkhof
Frederik
Barkhof
Gilles Edan
Gilles
Edan
Mark S Freedman
Mark S
Freedman
Xavier Montalbán
Xavier
Montalbán
Bertram Müller-Myhsok
Bertram
Müller-Myhsok
Bernhard Hemmer
Bernhard
Hemmer
MSJ763089_supplement – Supplemental material for Effect of <i>HLA-DRB1</i> alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials
SAGE Journals
2018
Multiple sclerosis
interferon beta
anti-drug antibodies
genetic variation
HLA-DRB1
genome-wide association study
2018-03-09 12:00:00
Journal contribution
https://sage.figshare.com/articles/journal_contribution/MSJ763089_supplement_Supplemental_material_for_Effect_of_i_HLA-DRB1_i_alleles_and_genetic_variants_on_the_development_of_neutralizing_antibodies_to_interferon_beta_in_the_BEYOND_and_BENEFIT_trials/6396683
<p>Supplemental material, MSJ763089_supplement for Effect of <i>HLA-DRB1</i> alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials by B Hemmer, Dorothea Buck, Mark Mühlau, Till FM Andlauer, Wilmar Igl, Eva-Maria Wicklein, Karl Köchert, Frank Weber, Christoph Pohl, Barry Arnason, Giancarlo Comi, Stuart Cook, Massimo Filippi, Hans-Peter Hartung, Douglas Jeffery, Ludwig Kappos, Frederik Barkhof, Gilles Edan, Mark S Freedman, Xavier Montalbán, Bertram Müller-Myhsok and Bernhard Hemmer in Multiple Sclerosis Journal</p>